Beginning in mid-February 2008, the 1997-2007 online version of the Science Watch® newsletter, ESI-Topics.com, and in-cites.com, will all be featured together on the redesigned ScienceWatch.com. All previous content from the three sites will be permanently archived, and remain accessible from any existing bookmarks to the archived pages. No new content will be added to this site. Updates and new content (updated biweekly) are available at ScienceWatch.com now.

New Hot Paper Comments

By COOKIES

ESI Special Topics, July 2003
Citing URL - http://www.esi-topics.com/nhp/2003/july-03-MassimoStefani.html

Prof. Massimo Stefani answers a few questions about this month's new hot paper in field of Multidisciplinary.

From •>>July 2003

Field: Multidisciplinary
Article Title: "Inherent toxicity of aggregates implies a common mechanism for protein misfolding diseases"
Authors: Bucciantini, M;Giannoni, E;Chiti, F;Baroni, F;Formigli, L;Zurdo, JS;Taddei, N;Ramponi, G;Dobson, CM;Stefani, M
Journal: NATURE
Volume: 416
Page: 507-511
Year: APR 4 2002
* Univ Florence, Dipartimento Sci Biochim, Viale Morgagni 50, I-50134 Florence, Italy.
* Univ Florence, Dipartimento Sci Biochim, I-50134 Florence, Italy.
* Univ Florence, Dipartimento Anat Istol & Med Legale, I-50134 Florence, Italy.
* Univ Cambridge, Dept Chem, Cambridge CB2 1EW, England.

ST:  Why do you think your paper is highly cited?

The paper is highly cited probably because it deals with a theme of great interest at present, i.e. the molecular basis of neurodegenerative and, most generally, degenerative diseases of amyloid basis, comprising very important human pathologies, either familial or sporadic, such as Alzheimer's and Parkinson's diseases.

ST:  Does it describe a new discovery or a new methodology that's useful to others?

The new data we have reported are innovative in the sense that they show for the first time that pre-fibrillar aggregates of proteins that are not related to any amyloid disease display cytotoxicity to cultured cells similarly to the corresponding pre-fibrillar aggregates formed in the differing amyloidoses, suggesting that most, possibly all proteins not only can potentially aggregate into amyloid fibrils but that their early aggregates are potentially cytotoxic. This suggests intriguing considerations on the molecular basis of amyloid diseases, particularly the sporadic forms linked to ageing, and on the tools evolution has set up to avoid the general risk that proteins can acquire toxic conformations and, when this happens, to efficiently counteract the appearance of these toxic materials.

ST:  What were some of the circumstances that led you to do this research?

This research is a consequence of my engagement in the field of protein folding and misfolding using model proteins we found to be able to aggregate into amyloid in vitro though not being involved in any known amyloid disease in vivo. The natural consequence was to investigate whether these aggregates were toxic to living systems and, if so, at what level of structural organization (i.e. pre-fibrillar aggregates, protofilament of mature fibrils).

ST:  Could you summarize the significance of your paper in layman's terms?

Showing that most, perhaps all, proteins are endowed with the intrinsic possibility to become toxic to cells, the paper provides new information on the molecular basis of amyloid diseases and suggests new clues on some aspects of protein and cell evolution.End

Massimo Stefani
Full Professor of Biochemistry
Dept. of Biochemical Sciences
University of Florence
Florence, Italy

This paper was most recently featured in Fast Breaking Papers - February 2003.
Read comments by this new hot paper's co-author Professor Christopher M. Dobson.

ESI Special Topics, July 2003
Citing URL - http://www.esi-topics.com/nhp/2003/july-03-MassimoStefani.html

•> Search Special Topics
New Hot Papers Menu || All Topics Menu
New Hot Papers Comments Menu
Help || About || Contact

ScienceWatch.com - Tracking Trends and Perfomance in Basic Research
Go to the new ScienceWatch.com

Write to the Webmaster with questions/comments. Terms of Usage.
The Research Services Group of Thomson Scientific |
(c) 2008 The Thomson Corporation.